Showing 1 - 2 results of 2 for search 'X.-N. Gao', query time: 0.02s Refine Results
  1. 1
    PB1821: COMBINATION OF BCL-2 INHIBITOR, HYPOMETHYLATION AGENTS AND LOW-DOSE CYTARABINE AS A SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES

    PB1821: COMBINATION OF BCL-2 INHIBITOR, HYPOMETHYLATION AGENTS AND LOW-DOSE CYTARABINE AS A SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES by X.-N. Gao, X. Lou, J. Lin, Y.-F. Su, J. Wang, L. Xu, H. Yu, A. Wang, Y.-Z. Wang, D.-H. Liu

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P533: SINGLE-CENTER PHASE 2 STUDY OF PD-1 INHIBITOR COMBINED WITH DNA DEMETHYLATION AGENT + CAG REGIMEN IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA: INTERIM ANALYSIS

    P533: SINGLE-CENTER PHASE 2 STUDY OF PD-1 INHIBITOR COMBINED WITH DNA DEMETHYLATION AGENT + CAG REGIMEN IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA: INTERIM ANALYSIS by X.-N. Gao, Y.-F. Su, Y. Jing, J. Wang, L. Xu, L.-L. Zhang, A. Wang, Y.-Z. Wang, Y.-F. Li, D.-H. Liu

    Published 2022-06-01
    Get full text
    Article

Search Tools: